Rachel E. Sobel

Vice President, Head Of Pharmacoepidemiology at Regeneron

Rachel E. Sobel, DrPH, FISPE, currently serves as Vice President and Head of Pharmacoepidemiology at Regeneron. Previously, Rachel held the position of Executive Director and Head of Pharmacoepidemiology at UBC and served as Senior Director and Group Lead in Epidemiology for Global Innovative Pharma at Pfizer, among other roles. Rachel's early career included a position as Research Coordinator in the Rheumatology Division at the Hospital for Special Surgery. Education includes a DrPH in Pharmacoepidemiology and an MPH in Environmental Health Sciences, both from Columbia University Mailman School of Public Health.

Links

Previous companies

UBC logo
Pfizer logo
Hospital for Special Surgery, Inc. logo

Timeline

  • Vice President, Head Of Pharmacoepidemiology

    January, 2024 - present

  • Executive Director, Head Of Pharmacoepidemiology

    January, 2021